Cardinal Health, Inc.

Cardinal Health, Inc.

CAHNYSE / NASDAQHealthcareLarge cap

$272.81+$0.47 (+0.2%)

Last close · Data as of Nov 20, 2026

Market cap
$47.2B
P/E
30.3x
EV / EBITDA
16.7x
Revenue
$222.6B
Net margin
0.7%
ROCE
16.3%

+31.2% over the last year

Cardinal Health, Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
+5.9%
3M
+19.4%
6M
+36.9%
1Y
+31.2%
5Y
+463.2%

52-week range

Day change +$0.47 (+0.2%) from $272 to $273 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in CAH, bought on each weekday since 2021.

News & filings

What Cardinal Health filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

ConcernShareholders' equity is negative: liabilities exceed assets.

Strengths (1)

  • Operating profit was 10.8 times interest costs.
  • Shareholders' equity is negative, so return on equity and debt to equity are not shown.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Read moreShow less

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Sector
Healthcare
Shares outstanding
240.9M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$47.2B
P/E
30.3x
P/B
-17.0x
EV / EBITDA
16.7x
EV / Sales
0.2x
P/S
0.2x
52-week high
$283.85
52-week low
$182.50

Profitability

Operating margin
1.0%
Net margin
0.7%
EBITDA margin
1.4%
ROE
-56.1%
ROCE
16.3%
ROA
2.9%
Asset turnover
4.19

Growth

Revenue
$222.6B
Revenue growth, 1Y
-1.9%
Revenue CAGR, 3Y
7.1%
Net profit growth, 1Y
83.2%
Free cash flow
$1.9B

Solvency

Current ratio
0.94
Debt / Equity
-3.07
Debt / Assets
0.16
CFO / Net profit
1.54
Cash / Market cap
8.2%

Where the revenue went

Of every $100 of FY2025 revenue, $1 was left as net income.

Cardinal Health, Inc. income statement flow, FY2025
Cardinal Health, Inc. income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$214.4B
RevenueGross profit$8.2B
Gross profitSelling, general and administrative$5.4B
Gross profitOther operating expenses$464.0M
Gross profitOperating income$2.3B
Operating incomePretax income$2.1B
Operating incomeInterest and other expense$221.0M
Pretax incomeTax and other$540.0M
Pretax incomeNet income$1.6B

Revenue and net profit

Revenue fell 1.9% in FY2025; net profit is the dashed line.

Cardinal Health, Inc. revenue and net profit by fiscal year
Cardinal Health, Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$181.3B-$938.0M
FY2023$205.0B$330.0M
FY2024$226.8B$852.0M
FY2025$222.6B$1.6B

Cash flows

FY2025: $2.4B from operations, $1.9B free after investment (dashed).

Cardinal Health, Inc. operating and free cash flow by fiscal year
Cardinal Health, Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$3.2B$2.8B
FY2023$2.8B$2.4B
FY2024$3.8B$3.3B
FY2025$2.4B$1.9B

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$222.6B-1.9%1Y
EBITDA
$3.1B+58.3%1Y
Net profit
$1.6B+83.2%1Y
Cash from operations
$2.4B-36.3%1Y
Free cash flow
$1.9B-43.1%1Y
Revenue CAGR, 3Y
7.1%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$222.6B$3.1B$1.6B$1.9B-56.1%-1.9%+83.2%

Monthly returns

Month-by-month returns of CAH across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$53.1B
Liabilities$55.8B
Equity-$2.6B
Retained earnings$783.0M
Treasury stock$6.4B
Minority interest$147.0M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; CAH highlighted.

P/E against peers

CAH trades at 30.3x earnings against a peer median of 38.7x (a 22% discount).

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
Cardinal Health, Inc.CAHthis companyP/E ↓ discount$47.2B30.3x-17.0x-56.1%16.7x
Cencora, Inc.COR$52.6B33.8x34.9x103.1%14.9x
Edwards Lifesciences CorporationEW$50.4B46.9x4.9x10.4%33.2x
IDEXX Laboratories, Inc.IDXX$44.5B42.0x27.7x66.0%30.1x
Humana Inc.HUM$42.0B35.4x2.4x6.7%—
Becton, Dickinson and CompanyBDX$41.2B24.6x1.6x6.6%12.1x
Alnylam Pharmaceuticals, Inc.ALNY$40.5B129.2x51.4x39.8%61.6x
Agilent Technologies, Inc.A$39.1B30.0x5.8x19.3%22.1x
Waters CorporationWAT$37.0B57.5x14.4x25.1%36.7x
Peer median—38.7x10.1x22.2%30.1x

Year-to-date ROI

CAH since 1 January, against earlier years.

Historical volatility

CAH's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

Cardinal Health, Inc. operating margin by fiscal year
Cardinal Health, Inc. operating margin by fiscal year
DateOperating margin
FY20220.9%
FY20230.9%
FY20240.9%
FY20251.0%
LineFY2025
Cost of revenueCost Of Revenue$214.4B
Gross profitGross Profit$8.2B
Operating expensesOperating Expense$5.8B
Selling, general and administrativeSelling General And Administration$5.4B
Depreciation and amortisationDepreciation And Amortization In Income Statement$464.0M
Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement$464.0M
Amortization$464.0M
Amortisation of intangiblesAmortization Of Intangibles Income Statement$464.0M
Total expensesTotal Expenses$220.3B
Pretax incomePretax Income$2.1B

Learn while you research

Academy chapters picked for Cardinal Health, Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Valuation Multiples ExplainedThis stock trades at a P/E of 30.3, learn when high multiples are justified.6 min read
  3. 03 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  4. 04 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  5. 05 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →